Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synflorix vs Prevenar 13 Booster in Children
NCT01443416Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Apr 2012
- Primary completion
- Aug 2013
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in invasive pneumococcal disease (IPD), otitis media, sponsored by University of Oxford. Started Apr 2012; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
invasive pneumococcal disease (IPD)otitis media
Beyond the preview
Go deeper on NCT01443416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01443416.